Related references
Note: Only part of the references are listed.Cancer stem cells: a potential target for cancer therapy
Hong Qiu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Therapeutic potential of cancer stem cells
Chunguang Yang et al.
MEDICAL ONCOLOGY (2015)
Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival
Matthew L. Fisher et al.
MOLECULAR CANCER RESEARCH (2015)
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
Francesco Spagnolo et al.
ONCOTARGETS AND THERAPY (2015)
Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
Matthew L. Fisher et al.
ONCOTARGET (2015)
12-O-Tetradecanoylphorbol-13-Acetate Induces Keratin 8 Phosphorylation and Reorganization via Expression of Transglutaminase-2
Eun Ji Lee et al.
BIOMOLECULES & THERAPEUTICS (2014)
Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration
Ambrish Kumar et al.
BMC CANCER (2014)
GPR56 Inhibits Melanoma Growth by Internalizing and Degrading Its Ligand TG2
Liquan Yang et al.
CANCER RESEARCH (2014)
Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor
Amy Lee Han et al.
EUROPEAN JOURNAL OF CANCER (2014)
Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways
Santosh Kumar et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion
Ahmed A. Ashour et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
TRANSGLUTAMINASE REGULATION OF CELL FUNCTION
Richard L. Eckert et al.
PHYSIOLOGICAL REVIEWS (2014)
Small Molecule Inhibitors Target the Tissue Transglutaminase and Fibronectin Interaction
Bakhtiyor Yakubov et al.
PLOS ONE (2014)
Crystal Structure of Transglutaminase 2 with GTP Complex and Amino Acid Sequence Evidence of Evolution of GTP Binding Site
Tae-Ho Jang et al.
PLOS ONE (2014)
New Biomarkers to Predict the Evolution of In Situ Breast Cancers
S. Bravaccini et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Recent advances in the development of tissue transglutaminase (TG2) inhibitors
E. Badarau et al.
AMINO ACIDS (2013)
Transglutaminases: key regulators of cancer metastasis
Alessandro Lentini et al.
AMINO ACIDS (2013)
Ethacrynic Acid Inhibits Sphingosylphosphorylcholine-Induced Keratin 8 Phosphorylation and Reorganization via Transglutaminase-2 Inhibition
Hyun Jung Byun et al.
BIOMOLECULES & THERAPEUTICS (2013)
Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype
Kevin D. Brown
BREAST CANCER RESEARCH AND TREATMENT (2013)
Gαh/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells
Yutaro Obara et al.
CELLULAR SIGNALLING (2013)
Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation
Mi Kyung Park et al.
EUROPEAN JOURNAL OF CANCER (2013)
Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism
Salvatore Condello et al.
FASEB JOURNAL (2013)
Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Jae-Heon Jeong et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2013)
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
Jun Fu et al.
NEURO-ONCOLOGY (2013)
The Role of TG2 in Regulating S100A4-Mediated Mammary Tumour Cell Migration
Zhuo Wang et al.
PLOS ONE (2013)
Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence
Jasmeet Assi et al.
PLOS ONE (2013)
Identification of a Population of Epidermal Squamous Cell Carcinoma Cells with Enhanced Potential for Tumor Formation
Gautam Adhikary et al.
PLOS ONE (2013)
Transglutaminase 2 expression in acute myeloid leukemia: Association with adhesion molecule expression and leukemic blast motility
Andrew Pierce et al.
PROTEOMICS (2013)
A Mechanism for the Upregulation of EGF Receptor Levels in Glioblastomas
Jingwen Zhang et al.
CELL REPORTS (2013)
Extracellular Tissue Transglutaminase Activates Noncanonical NF-κB Signaling and Promotes Metastasis in Ovarian Cancer
Bakhtiyor Yakubov et al.
NEOPLASIA (2013)
Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer
Navneet Agnihotri et al.
BREAST CANCER RESEARCH (2013)
Overexpression of phospho mutant forms of transglutaminase 2 downregulates epidermal growth factor receptor
Yi Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Detection of Transglutaminase 2 conformational changes in living cell
Marat S. Pavlyukov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN
Yi Wang et al.
BMC CANCER (2012)
GPR56 in cancer progression: current status and future perspective
Liquan Yang et al.
FUTURE ONCOLOGY (2012)
Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NFκB) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression
Lingbao Ai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
L. Cao et al.
ONCOGENE (2012)
Activation and Inhibition of Transglutaminase 2 in Mice
Laila Dafik et al.
PLOS ONE (2012)
Using FLIM-FRET to Measure Conformational Changes of Transglutaminase Type 2 in Live Cells
Nicholas S. Caron et al.
PLOS ONE (2012)
OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma
Chunguang Li et al.
PLOS ONE (2012)
Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells
Anupam Kumar et al.
BREAST CANCER RESEARCH (2012)
The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26
Panayiotis Kotsakis et al.
AMINO ACIDS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas
Liya Yuan et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
The transglutaminase 2 gene is aberrantly hypermethylated in glioma
Lisa M. Dyer et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Targeting Ovarian Tumor Cell Adhesion Mediated by Tissue Transglutaminase
May Khanna et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells
Anupam Kumar et al.
PLOS ONE (2011)
Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
Kapil Mehta et al.
Cancers (2011)
Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells
Keunhee Oh et al.
BREAST CANCER RESEARCH (2011)
Transglutaminase-dependent antiproliferative and differentiative properties of nimesulide on B16-F10 mouse melanoma cells
Angelo Gismondi et al.
AMINO ACIDS (2010)
TGM2 Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer
Norikatsu Miyoshi et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer
Kevin N. Dalby et al.
AUTOPHAGY (2010)
Potential for therapeutic targeting of tumor stem cells
Vaibhav Saini et al.
CANCER SCIENCE (2010)
Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5
Manuela Frese-Schaper et al.
FEBS LETTERS (2010)
Redox Regulation of Transglutaminase 2 Activity
Jorunn Stamnaes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Keratinocyte Stem Cells: Friends and Foes
Carlo Pincelli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Similar antineoplastic effects of nimesulide, a selective COX-2 inhibitor, and prostaglandin E1 on B16-F10 murine melanoma cells
Claudio Tabolacci et al.
MELANOMA RESEARCH (2010)
Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells
Anupam Kumar et al.
PLOS ONE (2010)
In vivo evaluation of type 2 transglutaminase contribution to the metastasis formation in melanoma
G. Di Giacomo et al.
AMINO ACIDS (2009)
Biological and therapeutic significance of tissue transglutaminase in pancreatic cancer
K. Mehta
AMINO ACIDS (2009)
Novel interactions of TG2 with heparan sulfate proteoglycans: reflection on physiological implications
E. A. M. Verderio et al.
AMINO ACIDS (2009)
Aldehyde Dehydrogenase-Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to Cancer
Joseph E. Carpentino et al.
CANCER RESEARCH (2009)
Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
Minghai Shao et al.
CANCER RESEARCH (2009)
Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis
Robert Kiraly et al.
FEBS JOURNAL (2009)
Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein Activity
Minati Satpathy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Pancreatic Cancer Stem Cells and Relevance to Cancer Treatments
Filip Bednar et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Intracellular Localization and Conformational State of Transglutaminase 2: Implications for Cell Death
Soner Gundemir et al.
PLOS ONE (2009)
Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
Hasan Korkaya et al.
PLOS BIOLOGY (2009)
New Therapeutics Targeting Colon Cancer Stem Cells
Arun Thenappan et al.
CURRENT COLORECTAL CANCER REPORTS (2009)
Synthesis of potent water-soluble tissue transglutaminase inhibitors
Martin Griffin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The bioorganic chemistry of transglutaminase - from mechanism to inhibition and engineering
Jeffrey W. Keillor et al.
CANADIAN JOURNAL OF CHEMISTRY (2008)
Significance of CD90+ cancer stem cells in human liver cancer
Zhen Fan Yang et al.
CANCER CELL (2008)
Clinical and biological significance of tissue transglutaminase in ovarian carcinoma
Jee Young Hwang et al.
CANCER RESEARCH (2008)
Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling
Liyun Cao et al.
CARCINOGENESIS (2008)
The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer
Lingbao Ai et al.
CARCINOGENESIS (2008)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells
Amit Verma et al.
CLINICAL CANCER RESEARCH (2008)
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer
Arnit Verma et al.
CLINICAL CANCER RESEARCH (2008)
Cancer Stem Cells: How can we Target them?
Ivan Ischenko et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Pancreatic cancer stem cells
Cheong J. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Application of a Global Proteomic Approach to Archival Precursor Lesions: Deleted in Malignant Brain Tumors 1 and Tissue Transglutaminase 2 Are Upregulated in Pancreatic Cancer Precursors
Wang Cheung et al.
PANCREATOLOGY (2008)
Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury
Matthew Siegel et al.
PLOS ONE (2008)
Hyaluronic acid induces transglutaminase II to enhance cell motility; role of Rac1 and FAK in the induction of transglutaminase II
Youngmi Kim et al.
BIOTECHNOLOGY LETTERS (2008)
Location, location, location: The cancer stem cell niche
Julie B. Sneddon et al.
CELL STEM CELL (2007)
Transglutaminase 2 undergoes a large conformational change upon activation
Daniel M. Pinkas et al.
PLOS BIOLOGY (2007)
Cancer stem cells as mediators of treatment resistance in brain tumors: Status and controversies
Per O. Sakariassen et al.
NEOPLASIA (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
PKCδ and tissue transglutarninase in pancreatic cancer cells are novel inhibitors of autophagy
Bulent Ozpolat et al.
AUTOPHAGY (2007)
Transglutaminase 2 inhibitors and their therapeutic role in disease states
Matthew Siegel et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase
Nbnati Satpathy et al.
CANCER RESEARCH (2007)
Tissue transglutaminase induces the release of apoptosis inducing factor and results in apoptotic death of pancreatic cancer cells
Jansina Y. Fok et al.
APOPTOSIS (2007)
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy
L. Yuan et al.
ONCOGENE (2007)
Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells
L. S. Mangala et al.
ONCOGENE (2007)
Tissue transglutaminase inhibits autophagy in pancreatic cancer cells
Ugur Akar et al.
MOLECULAR CANCER RESEARCH (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
GPR56 and TG2 - Possible roles in suppression of tumor growth by the microenvironment
Lei Xu et al.
CELL CYCLE (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Discovery and development of sulforaphane as a cancer chemopreventive phytochemical
Yuesheng Zhang et al.
ACTA PHARMACOLOGICA SINICA (2007)
Mechanism of allosteric regulation of transglutaminase 2 by GTP
Gillian E. Begg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Decrease of polyamine levels and enhancement of transglutaminase activity in selective reduction of B16-F10 melanoma cell proliferation induced by atrial natriuretic peptide
Patrizia M. Baldini et al.
MELANOMA RESEARCH (2006)
Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis
Amit Verma et al.
CANCER RESEARCH (2006)
Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-κB in cancer cells:: Delineation of a novel pathway
Aman P. Mann et al.
CANCER RESEARCH (2006)
GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis
Lei Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Implications of tissue transglutaminase expression in malignant melanoma
Jansina Y. Fok et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells
J. F. Herman et al.
ONCOGENE (2006)
Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity
GE Begg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cancer stem cells: An old idea - A paradigm shift
MS Wicha et al.
CANCER RESEARCH (2006)
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion
Lingegowda S. Mangala et al.
MOLECULAR CANCER (2005)
Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas
L Yuan et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Mammary stem cells, self-renewal pathways, and carcinogenesis
SL Liu et al.
BREAST CANCER RESEARCH (2005)
Self-renewal and solid tumor stem cells
M Al-Hajj et al.
ONCOGENE (2004)
Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis
JSK Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer
K Mehta et al.
CLINICAL CANCER RESEARCH (2004)
Tissue transglutaminase has intrinsic kinase activity - Identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase
S Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases
SE Iismaa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors
RL Zhang et al.
GLIA (2003)
In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer
N Martinet et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Transglutaminases: Crosslinking enzymes with pleiotropic functions
L Lorand et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity
SP Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Transglutaminase activity is involved in polyamine-induced programmed cell death
F Facchiano et al.
EXPERIMENTAL CELL RESEARCH (2001)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer
T Nishimura et al.
JOURNAL OF BIOCHEMISTRY (2001)
Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins α9β1 and α4β1
H Takahashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket
SE Iismaa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
